CaixaImpulse Health Innovation Call supports biomedical research teams with funding, mentoring and training to validate research assets and prepare them for commercialisation or licensing.
Funder: la Caixa Foundation
Due Dates (Anticipated): February 2027 (Application deadline)
Funding Amounts: Up to €50,000–€500,000 per stage over 12–24 months; up to €700,000 across all three stages
Summary: Funding, mentoring and training help biomedical teams validate research assets and develop strategies for transferring them to market.
Key Information: Applicant institutions must own or co-own the asset, with more than 50% held by public-sector or nonprofit institutions.
The CaixaImpulse Health Innovation Programme, run by la Caixa Foundation with Criteria Bio Ventures as a strategic collaborator, supports the transfer of biomedical research into products, services and businesses. It addresses the funding gap between early research grants and later commercial investment, helping entrepreneurial researchers validate assets and prepare for commercialisation or licensing. Eligible business areas are therapeutics, medical devices, diagnostics and digital health, with a focus on human health.
Teams can enter at one of three maturity stages, from initial proof of concept and intellectual property protection to prototype validation, advanced characterisation and regulatory preparation. Support combines project funding with mentors, specialist consultants and training in technology transfer, project management, finance, commercialisation and negotiation. Projects must identify relevant milestones towards market transfer.